Contact Us

*    Denotes required field.

   * First Name 

   * Last Name 

   * Email 


Cell Phone 

Street Address 

Zip Code 



Date you started taking this drug:

Date you stopped taking this drug:

Age of patient when antidepressant(s) prescribed:

What condition was this medication prescribed to treat?

What additional medications were you taking at the time?

Did patient hurt themselves during or after taking the drug?

Did patient become violent during or after taking the drug?

Was suicide attempted?

Was hospitalization or institutionalization required after taking antidepressant(s)?

Did loved one commit suicide?

If patient did attempt or commit suicide, did patient ever attempt suicide previously?

If patient did commit suicide, what was the method of suicide?

Please describe violent or suicidal behavior:

If you ever tried to stop taking Paxil and experienced withdrawal, please describe the withdrawal side effects:

Please further describe side effects:

For verification purposes, please answer the below question:

No Yes, I agree to the Parker Waichman LLP disclaimers. Click here to review.

Yes, I would like to receive the Parker Waichman LLP monthly newsletter, InjuryAlert.

please do not fill out the field below.

Paxil Warning Given To Teens

Jul 17, 2003 | The Canadian Press

Canada has followed in the footsteps of the United States and Britain, instructing doctors and parents that children under 18 shouldn't take a popular anti-depressant because it appears to trigger suicidal thoughts in some adolescent users.

GlaxoSmithKline, the makers of Paxil, admitted in a statement Tuesday that studies it conducted showed the drug also didn't appear to work in children who were taking it.

''First of all, it didn't show that it was effective for treating the depression in children and adolescents and then secondly there were these adverse events that were detected,'' said Dr. Anne Phillips, vice-president for research and development and chief medical officer for GlaxoSmithKline.

Those adverse affects ranged from mood fluctuations and increased crying to suicidal thoughts and suicide attempts, Phillips said.

A prominent British psychiatrist who has warned for years that the class of drugs to which Paxil belongs can trigger suicide in some users said the move to block the use of the drug in children should have happened earlier.

''Oh yes, (it's) way overdue,'' said Dr. David Healy in a telephone interview. Healy said Health Canada should follow suit with other drugs in the popular class of anti-depressants known as SSRIs, short for selective serotonin reuptake inhibitors.

A spokeswoman for Health Canada could not say if decisions to block use of other SSRIs among children were in the works. Krista Apse said she did not know if the department was reviewing the safety record of all SSRIs in children. But Phillips said she believes other such reviews will take place. ''It's our understanding that Health Canada will be looking at other products in similar class and classes,'' she said.

GlaxoSmithKline stressed that children currently taking Paxil must not discontinue its use abruptly. Discontinuing the medication should be done under a doctor's care, the company said, with a gradual reduction of dose recommended to minimize ''discontinuation symptoms.''

Related articles
Parker Waichman Accolades And Reviews Best Lawyers Find Us On Avvo